Markets:

Overview

News

Currencies

International

Treasuries

Upstream Bio, Inc. - Common Stock (NQ:UPB)

14.69 -13.12 (-47.18%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Upstream Bio, Inc. - Common Stock

Which stocks are experiencing notable movement on Wednesday? ↗

Today 15:00 EST

Via Chartmill

Top stock movements in today's session. ↗

Today 12:30 EST

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

Today 10:30 EST

Via Chartmill

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

Today 8:30 EST

Via Chartmill

Why Did UPB Stock Pop 20% In Pre-Market Today? ↗

Today 6:22 EST

The company announced positive top-line results from its Phase 2 VALIANT trial evaluating Verekitug in adults with severe asthma.

Via Stocktwits

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 02, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗

September 02, 2025

The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds ↗

September 02, 2025

Upstream Bio's Phase 2 trial of verekitug in chronic rhinosinusitis met all endpoints, showing reduced nasal polyps, congestion, and need for surgery.

Via Benzinga

Upstream Bio (UPB) Q2 R&D Soars 169% ↗

August 06, 2025

Via The Motley Fool

Alerus Financial Posts Better-Than-Expected Earnings, Joins Celcuity, SES AI, Abercrombie & Fitch And Other Big Stocks Moving Higher On Monday ↗

July 28, 2025

Via Benzinga

Topics Artificial Intelligence

Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency ↗

June 15, 2025

The company is progressing with multiple Phase 2 trials for its investigational treatment targeting severe respiratory diseases.

Via Stocktwits

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 28, 2025

Via Benzinga

Amtech Systems, Tesla And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

April 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 10, 2025

Via Benzinga

Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket ↗

April 10, 2025

Via Benzinga

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

March 12, 2025

From Upstream Bio

Via GlobeNewswire

Discover the 3 Best-Performing Biotech IPO Stocks of 2024

November 06, 2024

Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.

Via MarketBeat

Topics Initial Public Offering

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say ↗

November 05, 2024

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market.

Via Benzinga

This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

November 05, 2024

Via Benzinga

Another Trio Of Biotech IPOs Made Friday Debut ↗

October 13, 2024

The Partners Group-backed KinderCare sold 24 million shares for $24 each this past Tuesday. Meanwhile, a new trio of biotech companies' shares came to market on Friday, as Upstream Bio, CeriBell, and...

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.